{
  "retracted": false,
  "timestamp": 1556064000000,
  "updates": [
    {
      "timestamp": 1563005440535,
      "identifier": {
        "doi": "10.1007/s10637-019-00763-x"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10637-017-0525-1"
  },
  "journal": "Investigational New Drugs",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma"
}
